Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 1
2007 2
2010 2
2011 3
2012 5
2013 2
2014 4
2015 4
2016 4
2017 3
2018 4
2019 4
2020 2
2021 3
2022 8
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. Among authors: felicio js. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Present Insights on Cardiomyopathy in Diabetic Patients.
Felício JS, Koury CC, Carvalho CT, Abrahão Neto JF, Miléo KB, Arbage TP, Silva DD, de Oliveira AF, Peixoto AS, Figueiredo AB, Ribeiro Dos Santos ÂK, Yamada ES, Zanella MT. Felício JS, et al. Curr Diabetes Rev. 2016;12(4):384-395. doi: 10.2174/1573399812666150914120529. Curr Diabetes Rev. 2016. PMID: 26364799 Free PMC article. Review.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.
Global miRNA expression reveals novel nuclear and mitochondrial interactions in Type 1 diabetes mellitus.
Ferraz RS, Santos LCB, da-Silva-Cruz RL, Braga-da-Silva CH, Magalhães L, Ribeiro-Dos-Santos A, Vidal A, Vinasco-Sandoval T, Reis-das-Mercês L, Sena-Dos-Santos C, Pereira AL, Silva LSD, de Melo FTC, de Souza ACCB, Leal VSG, de Figueiredo PBB, Neto JFA, de Moraes LV, de Lemos GN, de Queiroz NNM, Felício KM, Cavalcante GC, Ribeiro-Dos-Santos Â, Felício JS. Ferraz RS, et al. Among authors: felicio js. Front Endocrinol (Lausanne). 2022 Nov 24;13:1033809. doi: 10.3389/fendo.2022.1033809. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36506063 Free PMC article.
[Endogenous hyperinsulinism: review and follow-up of 24 cases].
Felício JS, Martins CP, Semer M, Kalinin L, Nery M, Machado MC, Liberman B. Felício JS, et al. Arq Bras Endocrinol Metabol. 2012 Mar;56(2):83-95. doi: 10.1590/s0004-27302012000200001. Arq Bras Endocrinol Metabol. 2012. PMID: 22584561 Review. Portuguese.
Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
Gross JL, Kramer CK, Leitão CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ; Diabetes and Endocrinology Meta-analysis Group (DEMA). Gross JL, et al. Ann Intern Med. 2011 May 17;154(10):672-9. doi: 10.7326/0003-4819-154-10-201105170-00007. Ann Intern Med. 2011. PMID: 21576535 Free article. Review.
Glucagon test in insulinoma: Is it useful?
Felício JS, Martins CL, Mileo KB, Semer M, Kalinin L, Nery M, Machado MC, Liberman B. Felício JS, et al. J Endocrinol Invest. 2012 Jun;35(6):570-2. doi: 10.3275/7879. Epub 2011 Jul 27. J Endocrinol Invest. 2012. PMID: 21791970
High-dose Cholecalciferol Supplementation Reducing Morning Blood Pressure in Normotensive DM1 Patients.
de Queiroz NNM, de Melo FTC, de Souza Resende F, Janaú LC, de Souza Neto NJK, de Lemos MN, de Oliveira MCNI, de Alcântara AL, de Moraes LV, da Mota Queiroz A, de Souza ÍJA, Said NM, Dos Santos MC, de Souza D'Albuquerque Silva L, Motta ARB, de Sá Oliveira Dos Reis M, Lobato IJC, de Figueiredo PBB, de Souza ACCB, Freire Piani PP, Felício KM, Abrahão Neto JF, Felício JS. de Queiroz NNM, et al. Among authors: felicio js. Curr Diabetes Rev. 2021;17(3):378-386. doi: 10.2174/1573399816999200729131508. Curr Diabetes Rev. 2021. PMID: 32729423
54 results